Pfizer’s Covid-19 vaccine may be costly, hard to deliver in India
5 years ago 1 min read
In the event of regulators granting approval once the safety data were made available at the end of November, what are the problems in vaccine deployment we could encounter in India?
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push